Oppenheimer analysts maintained an Outperform rating on Modine Manufacturing (NYSE:MOD) shares with a $145.00 price target.

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

LEXINGTON, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

Hulu has renewed the hit series Tell Me Lies for a third season, sharing on social media: “couldn’t keep you waiting any ...

Western Pacific Wealth Management LP trimmed its holdings in Tesla, Inc. (NASDAQ:TSLA – Free Report) by 33.4% in the fourth ...

Walmart Inc. (NYSE:WMT – Get Free Report)’s stock price was up 0.7% during mid-day trading on Tuesday after Oppenheimer raised their price target on the stock from $100.00 to $110.00. Oppenheimer ...

As the Trump administration continues changing federal research and funding guidelines, the ‘Prince’ spoke to professors and ...

Matt Damon's packed schedule with Christopher Nolan's upcoming project hands Ben Affleck the lead in Netflix thriller.

The Movie Academy is revealing presenters for the 2025 Academy Awards. The first batch includes last year's lead acting ...

Chipotle's outlook didn't factor in Trump's new tariffs. Analysts note that it also didn't factor in any gains for potential new menu items - like honey chicken.